Pfizer Inc.PFENYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank7
3Y CAGR-16.1%
5Y CAGR-5.3%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-16.1%/yr
vs +2.9%/yr prior
5Y CAGR
-5.3%/yr
Recent deceleration
Acceleration
-19.0pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 24.12% | -15.3% |
| 2024 | 28.49% | +77.5% |
| 2023 | 16.05% | -60.8% |
| 2022 | 40.90% | +8.0% |
| 2021 | 37.88% | +19.8% |
| 2020 | 31.62% | -31.0% |
| 2019 | 45.79% | +25.4% |
| 2018 | 36.51% | -3.3% |
| 2017 | 37.77% | +30.4% |
| 2016 | 28.95% | - |